UPMC Medical Education Pediatric Infectious Diseases

Topics

• Antibiotic Resistance in Bacteria 390
• HIV Research and Treatment 244
• HIV/AIDS drug development and treatment 186
• Pneumonia and Respiratory Infections 141
• Bacterial Infections and Vaccines 117
• HIV/AIDS Research and Interventions 105
• Tuberculosis Research and Epidemiology 103
• SARS-CoV-2 and COVID-19 Research 96
• Antifungal resistance and susceptibility 90
• Vector-borne infectious diseases 81
• Cytomegalovirus and herpesvirus research 73
• Antimicrobial Resistance in Staphylococcus 71

Most cited

1. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.

   The Lancet. Infectious diseases · 2021 · 698 citations · Yohei Doi

2. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.

   The Lancet. Microbe · 2023 · 265 citations · Yohei Doi

3. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 287 citations · Ghady Haidar

4. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.

   MMWR. Morbidity and mortality weekly report · 2024 · 183 citations · Marian Michaels

5. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study.

   The Lancet. Infectious diseases · 2022 · 299 citations · Yohei Doi